Delivery Order 75N95018D00023-75N95020F00001
- Not listed
- This is a delivery order under a $15 million Indefinite Delivery Contract (IDC) awarded by the National Institute on Drug Abuse (NIDA) to Rutgers, The State University. The task order, valued at $2,807,643, is for the NIDA Center for Genetic Studies, which Rutgers operates to receive, process, store, and distribute de-identified clinical data and biospecimens from NIDA-funded addiction research grants and contracts. This supports NIDA's research objectives on genetic factors related to substance...
- This is a $1,647,593 firm-fixed-price delivery order awarded by the National Institutes of Health (NIH) National Institute on Drug Abuse (NIDA) to Rutgers, The State University of New Jersey. The award is for the NIDA Center for Genetic Studies, where Rutgers will receive, process, store, and distribute de-identified clinical data and biospecimens from NIDA-funded addiction research grants and contracts over a 5-year period from March 2023 to March 2028. This delivery order provides $1.6 million...
- This is a firm-fixed-price delivery order awarded by the National Institute on Drug Abuse (NIDA), an agency within the Department of Health and Human Services, to Rutgers, The State University of New Jersey. The contract, valued at $1,982,526.92, is for the NIDA Adolescent Brain Cognitive Development (ABCD) Study Genome Center and Biospecimens Repository. Rutgers, through its Research Financial Services Division, will receive, process, store, and distribute de-identified clinical data and...
- Rutgers, The State University of New Jersey was awarded a $2.5 million firm fixed-price delivery order against the National Institutes of Health National Institute on Drug Abuse's Center for Genetic Studies indefinite delivery/indefinite quantity contract. Under the one-year task order, Rutgers will provide research services in support of NIDA's mission to advance science on the causes and consequences of drug use and addiction and to apply that knowledge to improve individual and public health....
- This contract was awarded by the National Institutes of Health (NIH) National Institute on Drug Abuse (NIDA) to Rutgers, The State University to establish and operate the NIDA Center for Genetic Studies. The contract is a single-award Indefinite Delivery Contract valued at $2,144,869.96 to support the continued genetic research services for the Center between September 2019 and September 2022, with a potential extension through March 2028. The contract is not designated as a set-aside. As the...
- This contract award is for the NIDA Center for Genetic Studies, which is a single-award Indefinite Delivery Contract from the National Institute on Drug Abuse (NIDA), part of the Department of Health and Human Services National Institutes of Health. The prime contractor is Rutgers, The State University, through its Research Financial Services Division. The contract is for the establishment and operation of the NIDA Center for Genetic Studies, which involves receiving, processing, storing and...
- The National Institute on Drug Abuse (NIDA) Center for Genetic Studies awarded a $2.5 million firm fixed price delivery order contract to Rutgers, The State University Research Financial Services Division for the period of March 14, 2022 through March 13, 2023. As the prime contractor, Rutgers, The State University Research Financial Services Division will provide research services in support of NIDA's Center for Genetic Studies, with performance taking place in New Brunswick, New Jersey.
- Rutgers, The State University has been awarded a firm fixed price delivery order against the National Institute on Drug Abuse Indefinite Delivery Contract to provide genetic research services. The $26,238.10 contract from the Department of the Navy Bureau of Medicine and Surgery will support Rutgers' continued operation of the NIDA Center for Genetic Studies through December 2023. As the prime contractor, Rutgers will receive, process, store, and distribute de-identified clinical data and...
- This is a $16,252,811.88 definitive contract awarded by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) to Rutgers, The State University for biomedical research and development services. The contract has a firm fixed price pricing type and a period of performance through July 13, 2013. Rutgers, a major public research institution, will provide applied and exploratory biomedical research under this contract, which supports the NIDDK Genetics Repository program. This...
- The National Institute on Drug Abuse awarded a firm fixed-price purchase order to Rashid Adnan (UEI: LMD7VXK1MQV9) on March 6, 2020, with a ceiling value of $26,900. The contract, which was solicited without a set-aside designation, calls for the awardee to study the pathophysiology and develop related research deliverables, with work to be performed in Greenbelt, Maryland. The solicitation was posted on January 31, 2020, with a bid due date of February 14, 2020, and the contract ultimately...
- 75N95018D00023Indefinite Delivery Contract
- 75N95018D00023-75N95020F00001Delivery Order
This is a delivery order contract awarded by the National Institute on Drug Abuse (NIDA), part of the Department of Health and Human Services, to Rutgers, The State University of New Jersey. The contract is for the NIDA Center for Genetic Studies, with a period of performance from March 14, 2020 to March 13, 2021 and a ceiling value of $2,499,999.99. The contract was awarded as a Firm Fixed Price task order under a larger Indefinite Delivery Contract (IDC) that Rutgers holds with NIDA, which has a 5-year period of performance through 2028 and a total value of $15 million. Under this IDC, Rutgers receives, processes, stores, and distributes de-identified clinical data and biospecimens from NIDA-funded addiction research grants and contracts to support the institute's research on genetic factors related to substance use disorders. This task order is for specific data management and biospecimen handling activities. The contract did not utilize any set-aside designation.
Name | Description | Solicitation Number | FederalAgency | Type | PostedDate |
|---|---|---|---|---|---|
Application Development and Information Technology Services | 75N95020F00001 | Department of Health and Human Services National Institutes of Health National Institute on Drug Abuse | Special Notice 1/1 | 3/29/22, 12:02 PM |
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00001 | Funding Only Action | 0$ | 12/10/24 | |
| Not listed | Not listed | $2.5m | 3/6/20 |